• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种解决高BMI和脂肪肝患者CEUS成像问题的新技术。

A Novel Technology for Resolution of CEUS Imaging Problems in Patients With High BMI and Fatty Liver.

作者信息

Merrill Christina, Samuel Anna, Gupta Saransh, Wilson Stephanie R

机构信息

Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Department of Medicine, Division of Gastroenterology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

出版信息

J Ultrasound Med. 2023 Nov;42(11):2603-2614. doi: 10.1002/jum.16296. Epub 2023 Jul 4.

DOI:10.1002/jum.16296
PMID:37401549
Abstract

OBJECTIVES

In high-BMI patients with and without fatty liver, we evaluate performance of a commercially available specially designed ultrasound probe (SDP) for scanning at depth. Greyscale and contrast-enhanced ultrasound (CEUS) capability of SDP for parenchymal assessment and liver mass characterization, emphasizing HCC, is compared with standard curvilinear probes.

METHODS

This retrospective study included 60 patients. Fifty-five with measured BMI included 46/55 (84%) overweight or obese, and 9/55(16%) in the normal range with severe fatty liver. Fifty-six patients with focal liver abnormality included 37 with a mass and 19 with post-ablative treatment site. Masses included 23 confirmed malignancies, 15 HCC, 4 ICC, and 4 metastases. SDP followed suboptimal ultrasound using a standard probe. Images with varying fat content were compared for depth of penetration on greyscale and ability of CEUS to diagnose tumors.

RESULTS

SDP showed statistically significant improvement P = <.05 in CEUS penetration for all degrees of fatty liver (mild, moderate, and severe). In malignant tumors, SDP improved detection of lesion washout in the portal venous/late phase (PVP/LP) at depth >10 cm, and in all malignant masses (P < .05). Fifteen confirmed deep HCC showed arterial phase hyperenhancement on standard probe in 10/15 (67%) and 15/15 (100%) on SDP. PVP/LP washout on standard probe was shown in 4/15 (26%) and on SDP, 14/15, (93%). Therefore, 93% of LR-5 tumors were diagnosed with SDP. Removing necessity for biopsy.

CONCLUSIONS

Metabolic syndrome and obesity challenge ultrasound, especially CEUS. SDP overcame limitations of standard probes for CEUS penetration especially in fatty liver. SDP was optimal for the liver mass characterization by detecting washout.

摘要

目的

在高体重指数(BMI)且伴有或不伴有脂肪肝的患者中,我们评估一种市售的专门设计的超声探头(SDP)在深度扫描方面的性能。将SDP用于实质评估和肝脏肿块特征描述(重点是肝细胞癌(HCC))的灰阶及对比增强超声(CEUS)能力与标准曲线探头进行比较。

方法

这项回顾性研究纳入了60例患者。55例测量了BMI的患者中,46/55(84%)超重或肥胖,9/55(16%)BMI在正常范围但患有重度脂肪肝。56例有肝脏局灶性异常的患者中,37例有肿块,19例为消融治疗后的部位。肿块包括23例确诊的恶性肿瘤,15例HCC,4例肝内胆管癌(ICC)和4例转移瘤。SDP在使用标准探头进行次优超声检查后使用。比较不同脂肪含量的图像在灰阶上的穿透深度以及CEUS诊断肿瘤的能力。

结果

SDP在所有程度的脂肪肝(轻度、中度和重度)的CEUS穿透方面显示出统计学上的显著改善(P = <.05)。在恶性肿瘤中,SDP改善了深度>10 cm时门静脉/晚期(PVP/LP)病变消退的检测,在所有恶性肿块中也是如此(P <.05)。15例确诊的深部HCC在标准探头上动脉期表现为高增强的有10/15(67%),在SDP上为15/15(100%)。标准探头上PVP/LP消退的有4/15(26%),在SDP上为14/15(93%)。因此,93%的LR-5肿瘤用SDP得以诊断,无需活检。

结论

代谢综合征和肥胖对超声检查,尤其是CEUS构成挑战。SDP克服了标准探头在CEUS穿透方面的局限性,尤其是在脂肪肝中。SDP通过检测消退情况对肝脏肿块特征描述最为理想。

相似文献

1
A Novel Technology for Resolution of CEUS Imaging Problems in Patients With High BMI and Fatty Liver.一种解决高BMI和脂肪肝患者CEUS成像问题的新技术。
J Ultrasound Med. 2023 Nov;42(11):2603-2614. doi: 10.1002/jum.16296. Epub 2023 Jul 4.
2
Washout appearance of hepatocellular carcinomas using standardized contrast-enhanced ultrasound (CEUS) including an extended late phase observation - Real-world data from the prospective multicentre DEGUM study.使用标准化的超声造影(CEUS)观察肝细胞癌的洗脱现象,包括延长的晚期观察——来自前瞻性多中心 DEGUM 研究的真实世界数据。
Clin Hemorheol Microcirc. 2023;84(4):413-424. doi: 10.3233/CH-231740.
3
Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis.超声造影肝脏影像报告与数据系统:在肝细胞癌和胆管细胞癌诊断中的优缺点。
World J Gastroenterol. 2022 Jul 21;28(27):3488-3502. doi: 10.3748/wjg.v28.i27.3488.
4
Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.超声造影对肝细胞癌鉴别诊断的诊断准确性:爱克发与CEUS-LI-RADS对比
Eur J Gastroenterol Hepatol. 2017 Sep;29(9):1036-1044. doi: 10.1097/MEG.0000000000000916.
5
Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?增强超声能区分肝内胆管细胞癌和肝细胞癌吗?
World J Gastroenterol. 2020 Jul 21;26(27):3938-3951. doi: 10.3748/wjg.v26.i27.3938.
6
Additional value of contrast-enhanced ultrasound (CEUS) on arterial phase non-hyperenhancement observations (≥ 2 cm) of CT/MRI for high-risk patients: focusing on the CT/MRI LI-RADS categories LR-3 and LR-4.增强超声(CEUS)对 CT/MRI 动脉期非高增强观察(≥2cm)的附加价值(高危患者):重点关注 CT/MRI LI-RADS 类别 LR-3 和 LR-4。
Abdom Radiol (NY). 2020 Jan;45(1):55-63. doi: 10.1007/s00261-019-02132-x.
7
Tips and Tricks in Contrast-Enhanced Ultrasound (CEUS) for the Characterization and Detection of Liver Malignancies.超声造影(CEUS)在肝脏恶性肿瘤特征与检测中的技巧。
Ultraschall Med. 2019 Aug;40(4):404-424. doi: 10.1055/a-0900-3962. Epub 2019 Aug 5.
8
Interobserver Agreement for Contrast-Enhanced Ultrasound (CEUS)-Based Standardized Algorithms for the Diagnosis of Hepatocellular Carcinoma in High-Risk Patients.基于增强超声(CEUS)的标准化算法在高危患者中诊断肝细胞癌的观察者间一致性。
Ultraschall Med. 2018 Dec;39(6):667-674. doi: 10.1055/a-0612-7887. Epub 2018 Jun 7.
9
Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.超声造影使用声诺维®(六氟化硫微泡)与对比增强计算机断层扫描和对比增强磁共振成像在局灶性肝脏病变的特征描述和肝转移检测中的比较:系统评价和成本效益分析。
Health Technol Assess. 2013 Apr;17(16):1-243. doi: 10.3310/hta17160.
10
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.在一项多中心回顾性研究中,1006 个结节的对比超声 LI-RADS LR-5 可识别肝硬化中的肝细胞癌。
J Hepatol. 2018 Mar;68(3):485-492. doi: 10.1016/j.jhep.2017.11.007. Epub 2017 Nov 11.

引用本文的文献

1
Risk Factors for Early Recurrence After Radical Resection of Hepatocellular Carcinoma Based on Preoperative Contrast-Enhanced Ultrasound and Clinical Features.基于术前增强超声和临床特征的肝细胞癌根治性切除术后早期复发的危险因素。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241281327. doi: 10.1177/15330338241281327.